AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2019
Sep 10, 2019
30786_dirs_2019-09-10_3c1accff-aa30-4f00-bfc1-2de8b0c97f2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-09
Reporting Person: HERTIA JOHN (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-09 | Bio-Rad A Common Stock | M | 600 | $159.32 | Acquired | 18206 | Direct |
| 2019-09-09 | Bio-Rad A Common Stock | S | 444 | $336.47 | Disposed | 17762 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-09 | Non-Qualified Stock Option (right to buy) | $159.32 | M | 600 | Disposed | 2026-09-07 | Bio-Rad A Common Stock (600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 252 | Indirect |
Footnotes
F1: The option vests in five equal annual installments beginning September 7, 2017.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13